1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Robert A. Winn Excellence in Clinical Trials Award Program is sponsored by Bristol Myers Squibb Foundation. Established by the Bristol Myers Squibb Foundation, this program aims to improve participation in clinical trials by training the next generation of clinical research scientists in community engagement.
The goal is to include more diverse patient populations in clinical trials.
Get alerted about grants like this
Save a search for “Bristol Myers Squibb Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Clinical trials - Bristol Myers Squibb Foundation Developing community-oriented clinical trialists At the BMS Foundation, we believe that improving participation in clinical trials is a critical part of advancing global health. The Robert A.
Winn Excellence in Clinical Trials Award Program, established by the Bristol Myers Squibb Foundation, is training the next generation of clinical research scientists, who have the potential to transform the clinical research landscape, with knowledge, skills and competencies in high quality clinical trials, and the unique science of effective community outreach and engagement.
It also exposes medical students to clinical research career pathways. Winn Awards Program snapshot $124. 5 MM Contribution ($100 MM from BMS Foundation, $24.
5 MM from Funding Partners Amgen, Gilead Sciences and Genentech) 316 clinical trial investigators Winn Awards Program snapshot</b>" data-classname="external-link-warning-modal" data-url="/content/bms/us/en_us. warning. html"> Learn more about the Winn Awards “We believe that this program is not only innovative, but we believe that this program was necessary.
The Winn Awards doesn't just do something different. It does a different thing. And that different thing is to create a work force that results in solving the problem, and having an unmet need met of getting people from rural areas and at-risk areas onto clinical trials.
This is the training force of tomorrow. ” Robert A. Winn, MD, director, Massey Comprehensive Cancer Center, Virginia Commonwealth University, namesake of and chair of the National Advisory Committee for the Robert A.
Winn Excellence in Clinical Trials Award program “What I love about this program is that we not only have the opportunity to be mentored, but also to be a mentor -- it is a sustainable initiative. We are inspiring soon-to-be physicians to be investigators one day. It is a brilliant, beautiful pipeline.
” Oluwadamilola Oladeru, MD “Every clinical trial involves the unknown. Therefore, the currency for clinical trials is trust. Patients have to be able to trust that the researchers have their best interests in mind and are being transparent about what they are doing.
And fostering that type of trust requires a real connection. ” “Anytime a patient goes on a clinical trial, that is a gift to humanity -- one patient’s involvement can make a significant impact down the road for all of humanity. ”
According to the current listing, eligibility includes: Clinical trial investigators and medical students; page does not provide detailed eligibility criteria — refers to diversityinclinicaltrials.org for details. Confirm the full requirements in the official notice before applying.
The current listing shows $124.5 million (total program contribution). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The Robert A. Winn Excellence in Clinical Trials Award Program is funded by Bristol Myers Squibb Foundation. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Sickle Cell Disease program (part of Pediatric Cancers and Blood Disorders focus area) is sponsored by Bristol Myers Squibb Foundation. The BMS Foundation, in partnership with Baylor College of Medicine Global Health and Texas Children's Global HOPE Program, supports initiatives to transform pediatric care for sickle cell disease (SCD) in sub-Saharan Africa. This includes building local healthcare capacity and integrating SCD interventions into primary health services.
Bristol Myers Squibb Health Equity Initiatives is a grant from the Bristol Myers Squibb Foundation that funds programs working to remove barriers to quality care for medically underserved and diverse patient populations. Grants ranging from $50,000 to $250,000 support disease awareness and education, health equity initiatives, and other programs aligned with BMS's therapeutic areas of interest including oncology, hematology, immunology, and cardiovascular disease. The foundation accepts applications throughout the year and prioritizes initiatives that improve access to care and advance health equity for all. Eligible applicants are U.S.-based 501(c)(3) nonprofit organizations or academic institutions. International funding opportunities may differ.